These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11583969)

  • 41. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
    Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
    Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC; Cheng W; Lai PL
    Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
    Haas S; Gütgemann I; Wolff M; Fischer HP
    Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas.
    Borscheri N; Roessner A; Röcken C
    Am J Surg Pathol; 2001 Oct; 25(10):1297-303. PubMed ID: 11688465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers.
    Man XB; Tang L; Zhang BH; Li SJ; Qiu XH; Wu MC; Wang HY
    Liver Int; 2005 Oct; 25(5):962-6. PubMed ID: 16162153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
    Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
    Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocyte expressions in hepatocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diagnostic marker.
    Lee HS; Kim WH; Kang GH
    J Korean Med Sci; 2003 Dec; 18(6):842-8. PubMed ID: 14676441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1.
    Magerl C; Ellinger J; Braunschweig T; Kremmer E; Koch LK; Höller T; Büttner R; Lüscher B; Gütgemann I
    Hum Pathol; 2010 Feb; 41(2):181-9. PubMed ID: 19896696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
    Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
    Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A resected case of a small hepatocellular carcinoma developing within the bile duct.
    Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H
    J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers.
    Porcell AI; De Young BR; Proca DM; Frankel WL
    Mod Pathol; 2000 Jul; 13(7):773-8. PubMed ID: 10912937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of mucin core protein of mammary type in primary liver cancer.
    Sasaki M; Nakanuma Y
    Hepatology; 1994 Nov; 20(5):1192-7. PubMed ID: 7523272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.